Download FREE Report Sample
Download Free sampleA botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
Botanical and Plant Derivative Drug Market contains market size and forecasts of Botanical and Plant Derivative Drug in Global, including the following market information:
Global Botanical and Plant Derivative Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Botanical and Plant Derivative Drug market was valued at 48790 million in 2021 and is projected to reach US$ 72710 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Botanical and Plant Derivative Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Botanical and Plant Derivative Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Botanical and Plant Derivative Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Botanical and Plant Derivative Drug Market Segment Percentages, by Type, 2021 (%)
Prescription Drug
OTC
Global Botanical and Plant Derivative Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Botanical and Plant Derivative Drug Market Segment Percentages, by Application, 2021 (%)
Cardiovascular
Tumor
Respiratory System
Other
Global Botanical and Plant Derivative Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Botanical and Plant Derivative Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Botanical and Plant Derivative Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Botanical and Plant Derivative Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
